{
  "vector": {
    "response": "In the Netherlands, Metformine is typically the first choice for medication in diabetes treatment, following leefstijladvies (lifestyle advice). Newer medications like SGLT2-remmers and GLP-1 receptor agonists are considered when Metformine is not sufficient, particularly for patients with specific complications. In the United States, Metformin is also a standard first-line pharmacological treatment. However, newer agents like SGLT2 inhibitors and GLP-1 receptor agonists are increasingly considered for patients with established cardiovascular disease or chronic kidney disease, based on clinical trial evidence from the American Diabetes Association (ADA).",
    "source_nodes": [
      {
        "metadata": {
          "file_path": "/Users/shivam/Desktop/MedRAG/data/source_2_rivm.txt",
          "file_name": "source_2_rivm.txt",
          "file_type": "text/plain",
          "file_size": 674,
          "creation_date": "2025-06-26",
          "last_modified_date": "2025-06-26"
        },
        "score": 0.6682893916875497,
        "content": "Titel: Nederlandse RIVM Richtlijnen voor Diabetes Type 2\n\nIn Nederland richt de behandeling van diabetes type 2 zich op praktische, in het dagelijks leven geïntegreerde leefstijlaanpassingen. Het hoofddoel is het bereiken van een duurzaam gezond gewicht, met een streefdoel van 5-15% gewichtsverlies. Het voedingsadvies is gebaseerd op de 'Schijf van Vijf' (Wheel of Five), vaak aangescherpt met een koolhydraatbeperkt dieet. De beweegrichtlijn adviseert een combinatie van duurtraining (minimaal 150 minuten per week) en tweemaal per week spierversterkende oefeningen. De behandeling met medicatie volgt een 'stap-voor-stap' protocol, waarbij Metformine de eerste keus is."
      },
      {
        "metadata": {
          "file_path": "/Users/shivam/Desktop/MedRAG/data/rivm_diabetes.txt",
          "file_name": "rivm_diabetes.txt",
          "file_type": "text/plain",
          "file_size": 2200,
          "creation_date": "2025-06-26",
          "last_modified_date": "2025-06-26"
        },
        "score": 0.6595290296718254,
        "content": "Titel: Nederlandse RIVM Richtlijnen: Geïntegreerde Zorg voor Diabetes Type 2 en Volksgezondheid\n\nIn Nederland richt de behandeling van diabetes type 2 zich op praktische, in het dagelijks leven geïntegreerde leefstijlaanpassingen, vaak onder begeleiding van de huisarts en praktijkondersteuner (POH). Het hoofddoel is het bereiken van een duurzaam gezond gewicht, waarbij een gewichtsverlies van 5-15% aanzienlijke voordelen kan bieden, en het verbeteren van de insulinegevoeligheid. De Nederlandse gezondheidszorg, bekend om zijn sterke eerstelijnszorg, prioriteert preventieve maatregelen, waaronder nationale vaccinatieprogramma's voor kinderen.\n\nHet voedingsadvies is breed en gebaseerd op de 'Schijf van Vijf' (Wheel of Five), de algemene Nederlandse richtlijn voor gezonde voeding. Voor diabetespatiënten wordt dit vaak aangescherpt met een koolhydraatbeperkt dieet, waarbij de nadruk ligt op het vervangen van snelle suikers en 'witte' graanproducten door volkoren varianten, groenten, en peulvruchten. Echter, een recent overzicht van de Nederlandse Diabetes Federatie (NDF) suggereert dat rigide dieetrestricties minder effectief zijn dan flexibele, patiëntgerichte benaderingen. Regelmaat in maaltijden en het vermijden van overmatige alcoholconsumptie zijn essentieel. De RIVM publiceert ook jaarlijks rapporten over luchtkwaliteit in stedelijke gebieden.\n\nDe beweegrichtlijn adviseert een combinatie van duurtraining (minimaal 150 minuten per week matig intensief, zoals fietsen of wandelen) en tweemaal per week spierversterkende oefeningen. Dit draagt bij aan zowel gewichtsbeheersing als cardiovasculaire gezondheid. De behandeling met medicatie volgt een 'stap-voor-stap' protocol, waarbij Metformine de eerste keus is na leefstijladvies. Nieuwere medicijnen zoals SGLT2-remmers worden overwogen bij onvoldoende effect of specifieke complicaties. De huisarts en de POH vormen het hart van het zorgteam, met specialisten (internisten, diëtisten) in de tweede lijn voor complexe gevallen. Discussies over de integratie van eHealth-oplossingen in diabeteszorg zijn aan de gang. De kwaliteit van drinkwater in Nederland is ook van hoog niveau, wat bijdraagt aan algemene gezondheid."
      },
      {
        "metadata": {
          "file_path": "/Users/shivam/Desktop/MedRAG/data/cdc_diabetes.txt",
          "file_name": "cdc_diabetes.txt",
          "file_type": "text/plain",
          "file_size": 2515,
          "creation_date": "2025-06-26",
          "last_modified_date": "2025-06-26"
        },
        "score": 0.6476168918600279,
        "content": "Title: US CDC Guidelines: Comprehensive Diabetes Management and Prevention - Key Insights\n\nThe primary strategy for preventing Type 2 diabetes in the United States involves the National Diabetes Prevention Program (National DPP), a structured, yearlong lifestyle intervention. This program, facilitated by trained coaches, has demonstrated a significant reduction in disease risk for high-risk individuals, often achieving 5-7% body weight loss and at least 150 minutes of moderate physical activity, like brisk walking, each week. Furthermore, recent studies funded by NIH suggest that early identification of genetic predispositions might enhance prevention strategies, though these are not yet integrated into mainstream public health programs. The CDC also issues annual health advisories regarding seasonal flu vaccinations.\n\nFor individuals already diagnosed, Diabetes Self-Management Education and Support (DSMES) services are critical. These services help patients develop skills for managing blood sugar, reducing the risk of complications such as neuropathy or kidney disease, and coping with the emotional aspects of the disease. Effective management typically targets A1C levels below 7% for most non-pregnant adults. The CDC's dietary guidance promotes the 'plate method' for portion control, focusing on lean proteins and non-starchy vegetables, rather than prescribing a single, rigid diet. There's also an emphasis on adequate hydration and public awareness campaigns about the importance of handwashing.\n\nMetformin is the standard first-line pharmacological treatment. However, newer agents like SGLT2 inhibitors and GLP-1 receptor agonists are increasingly considered for patients with established cardiovascular disease or chronic kidney disease, based on recent clinical trial evidence from the American Diabetes Association (ADA). The interdisciplinary healthcare team, comprising primary care physicians, endocrinologists, and registered dietitians, collaborates to create personalized management plans. There's also an ongoing federal initiative to improve health equity in diabetes care among underserved populations through telemedicine, though this primarily impacts access, not core treatment guidelines.\n\nThe CDC's prevention strategies also encompass regular health screenings and community-based interventions, like promoting access to healthy food options in food deserts. Global health security remains a top priority, with efforts to monitor emerging infectious diseases worldwide."
      }
    ],
    "time": 6.406955003738403,
    "tokens": 85,
    "metrics": {
      "source_diversity": 0.75,
      "clinical_completeness": 0.5,
      "cross_guideline_synthesis": 0.3333333333333333,
      "evidence_strength": 0.658478437739801
    }
  },
  "rerank": {
    "response": "In the United States, Metformin is the standard first-line pharmacological treatment for diabetes. Recent clinical trial evidence from the American Diabetes Association (ADA) suggests newer agents like SGLT2 inhibitors and GLP-1 receptor agonists are increasingly considered for patients with established cardiovascular disease or chronic kidney disease. In the Netherlands, Metformin is also a first-line treatment. However, pharmacological interventions for weight loss are typically considered only in cases of severe obesity and after lifestyle modifications have failed.",
    "source_nodes": [
      {
        "metadata": {
          "file_path": "/Users/shivam/Desktop/MedRAG/data/source_1_cdc.txt",
          "file_name": "source_1_cdc.txt",
          "file_type": "text/plain",
          "file_size": 734,
          "creation_date": "2025-06-26",
          "last_modified_date": "2025-06-26"
        },
        "score": 0.5845526456832886,
        "content": "Title: US CDC Comprehensive Framework for Type 2 Diabetes Management\n\nThe cornerstone of Type 2 diabetes prevention in the United States involves the National Diabetes Prevention Program (National DPP), a structured, yearlong lifestyle intervention. This program, facilitated by trained coaches, has demonstrated a significant reduction in disease risk for high-risk individuals. Core goals include a modest weight loss of 5-7% of body weight and achieving at least 150 minutes of moderate physical activity, like brisk walking, each week. The CDC's dietary guidance promotes the 'plate method' for portion control, focusing on lean proteins and non-starchy vegetables. Metformin is the standard first-line pharmacological treatment."
      },
      {
        "metadata": {
          "file_path": "/Users/shivam/Desktop/MedRAG/data/source_2_rivm.txt",
          "file_name": "source_2_rivm.txt",
          "file_type": "text/plain",
          "file_size": 674,
          "creation_date": "2025-06-26",
          "last_modified_date": "2025-06-26"
        },
        "score": 0.5742115378379822,
        "content": "Titel: Nederlandse RIVM Richtlijnen voor Diabetes Type 2\n\nIn Nederland richt de behandeling van diabetes type 2 zich op praktische, in het dagelijks leven geïntegreerde leefstijlaanpassingen. Het hoofddoel is het bereiken van een duurzaam gezond gewicht, met een streefdoel van 5-15% gewichtsverlies. Het voedingsadvies is gebaseerd op de 'Schijf van Vijf' (Wheel of Five), vaak aangescherpt met een koolhydraatbeperkt dieet. De beweegrichtlijn adviseert een combinatie van duurtraining (minimaal 150 minuten per week) en tweemaal per week spierversterkende oefeningen. De behandeling met medicatie volgt een 'stap-voor-stap' protocol, waarbij Metformine de eerste keus is."
      },
      {
        "metadata": {
          "file_path": "/Users/shivam/Desktop/MedRAG/data/cdc_diabetes.txt",
          "file_name": "cdc_diabetes.txt",
          "file_type": "text/plain",
          "file_size": 2515,
          "creation_date": "2025-06-26",
          "last_modified_date": "2025-06-26"
        },
        "score": 0.5579286217689514,
        "content": "Title: US CDC Guidelines: Comprehensive Diabetes Management and Prevention - Key Insights\n\nThe primary strategy for preventing Type 2 diabetes in the United States involves the National Diabetes Prevention Program (National DPP), a structured, yearlong lifestyle intervention. This program, facilitated by trained coaches, has demonstrated a significant reduction in disease risk for high-risk individuals, often achieving 5-7% body weight loss and at least 150 minutes of moderate physical activity, like brisk walking, each week. Furthermore, recent studies funded by NIH suggest that early identification of genetic predispositions might enhance prevention strategies, though these are not yet integrated into mainstream public health programs. The CDC also issues annual health advisories regarding seasonal flu vaccinations.\n\nFor individuals already diagnosed, Diabetes Self-Management Education and Support (DSMES) services are critical. These services help patients develop skills for managing blood sugar, reducing the risk of complications such as neuropathy or kidney disease, and coping with the emotional aspects of the disease. Effective management typically targets A1C levels below 7% for most non-pregnant adults. The CDC's dietary guidance promotes the 'plate method' for portion control, focusing on lean proteins and non-starchy vegetables, rather than prescribing a single, rigid diet. There's also an emphasis on adequate hydration and public awareness campaigns about the importance of handwashing.\n\nMetformin is the standard first-line pharmacological treatment. However, newer agents like SGLT2 inhibitors and GLP-1 receptor agonists are increasingly considered for patients with established cardiovascular disease or chronic kidney disease, based on recent clinical trial evidence from the American Diabetes Association (ADA). The interdisciplinary healthcare team, comprising primary care physicians, endocrinologists, and registered dietitians, collaborates to create personalized management plans. There's also an ongoing federal initiative to improve health equity in diabetes care among underserved populations through telemedicine, though this primarily impacts access, not core treatment guidelines.\n\nThe CDC's prevention strategies also encompass regular health screenings and community-based interventions, like promoting access to healthy food options in food deserts. Global health security remains a top priority, with efforts to monitor emerging infectious diseases worldwide."
      },
      {
        "metadata": {
          "file_path": "/Users/shivam/Desktop/MedRAG/data/source_3_noise_cardiovascular.txt",
          "file_name": "source_3_noise_cardiovascular.txt",
          "file_type": "text/plain",
          "file_size": 582,
          "creation_date": "2025-06-26",
          "last_modified_date": "2025-06-26"
        },
        "score": 0.5523104667663574,
        "content": "Title: General Cardiovascular Health Guidelines (European Society of Cardiology)\n\nMaintaining cardiovascular health involves regular physical activity, aiming for 150-300 minutes of moderate-intensity exercise weekly. Dietary patterns should be rich in fruits, vegetables, and whole grains, while limiting sodium and saturated fats. Medications such as statins are often prescribed to manage cholesterol levels, a key risk factor for heart disease. Blood pressure management is also critical. These recommendations are foundational for preventing events like myocardial infarction."
      },
      {
        "metadata": {
          "file_path": "/Users/shivam/Desktop/MedRAG/data/source_4_noise_obesity_report.txt",
          "file_name": "source_4_noise_obesity_report.txt",
          "file_type": "text/plain",
          "file_size": 671,
          "creation_date": "2025-06-26",
          "last_modified_date": "2025-06-26"
        },
        "score": 0.5296741127967834,
        "content": "Title: Public Health Report on Obesity Trends in Western Europe\n\nRecent trends indicate a rising prevalence of obesity across Western Europe, which is a major public health concern. Government initiatives focus on promoting healthier food choices in schools and subsidizing sports club memberships. While pharmacological interventions for weight loss exist, they are typically considered only in cases of severe obesity and after lifestyle modifications have failed. The focus remains on prevention through education and community programs. Metformin is sometimes used off-label in certain patient populations for weight management, but this is not a standard guideline."
      }
    ],
    "time": 5.816204071044922,
    "tokens": 76,
    "metrics": {
      "source_diversity": 0.75,
      "clinical_completeness": 0.6666666666666666,
      "cross_guideline_synthesis": 0.3333333333333333,
      "evidence_strength": 0.5597354769706726
    }
  }
}